Cargando…

Association of microRNA Expression and BRAF(V600E) Mutation with Recurrence of Thyroid Cancer

Many miRNAs and cancer-related mutations have been proposed as promising molecular markers of papillary thyroid carcinoma (PTC). However, there are limited data on the correlation between miRNA expression, BRAF(V600E) mutation, and PTC recurrence. Therefore, to evaluate the potential of BRAF(V600E)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pamedytyte, Daina, Simanaviciene, Vaida, Dauksiene, Dalia, Leipute, Enrika, Zvirbliene, Aurelija, Sarauskas, Valdas, Dauksa, Albertas, Verkauskiene, Rasa, Zilaitiene, Birute
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226510/ https://www.ncbi.nlm.nih.gov/pubmed/32316638 http://dx.doi.org/10.3390/biom10040625

Ejemplares similares

SAT-LB096 Relationship between MicroRNA Expression Levels and Clinicopathological Parameters and Recurrence of Papillary Thyroid Carcinoma
por: Pamedytyte, Daina, et al.
Publicado: (2019)

Different stability of miRNAs and endogenous control genes in archival specimens of papillary thyroid carcinoma
por: Pamedytyte, Daina, et al.
Publicado: (2020)

MON-LB82 Plasma Expression Level of MiRNA -21 Is Related With the Presence of Papillary Thyroid Cancer
por: Zilaitiene, Birute, et al.
Publicado: (2020)

Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer
por: Kondrotienė, Aistė, et al.
Publicado: (2020)

Papillary Thyroid Carcinoma Tissue miR-146b, -21, -221, -222, -181b Expression in Relation with Clinicopathological Features
por: Kondrotienė, Aistė, et al.
Publicado: (2021)

The Role of TSHR, PTEN and RASSF1A Promoters’ Methylation Status for Non-Invasive Detection of Papillary Thyroid Carcinoma
por: Klimaitė, Raimonda, et al.
Publicado: (2022)

Challenging diagnosis of cervical vagal nerve schwannoma
por: Pankratjevaite, Lina, et al.
Publicado: (2022)

Factors Associated with the Prevalence of Thyroid Nodules and Goiter in Middle-Aged Euthyroid Subjects
por: Dauksiene, Dalia, et al.
Publicado: (2017)

Corrigendum to “Factors Associated with the Prevalence of Thyroid Nodules and Goiter in Middle-Aged Euthyroid Subjects”
por: Dauksiene, Dalia, et al.
Publicado: (2019)

Integration of human papillomavirus type 16 in cervical cancer cells
por: Gudleviciene, Zivile, et al.
Publicado: (2014)

The impact of FSH receptor polymorphism on time-to-pregnancy: a cross-sectional single-centre study
por: Zilaitiene, Birute, et al.
Publicado: (2018)

Relationship between Echocardiographic and Magnetic Resonance-Derived Measurements of the Thoracic Aorta in Turner Syndrome Patients
por: Krikščiūnienė, Rūta, et al.
Publicado: (2019)

The Use of Recombinant Pseudotype Virus-Like Particles Harbouring Inserted Target Antigen to Generate Antibodies against Cellular Marker p16(INK4A)
por: Lasickienė, Rita, et al.
Publicado: (2012)

Cardiometabolic Health in Adolescents and Young Adults with Congenital Adrenal Hyperplasia
por: Navardauskaite, Ruta, et al.
Publicado: (2022)

HRQOL after endoscopic transaxillary gasless hemithyroidectomy
por: Jasaitis, Kristijonas, et al.
Publicado: (2023)

Combination of Dabrafenib and Trametinib for the Treatment of Relapsed and Refractory Multiple Myeloma Harboring BRAF V600E Mutation
por: Čepulytė, Rūta, et al.
Publicado: (2020)

The Link between Thyroid Autoimmunity, Depression and Bipolar Disorder
por: Jucevičiūtė, Neringa, et al.
Publicado: (2019)

The BRAF(V600E) mutation: what is it really orchestrating in thyroid cancer?
por: Nucera, Carmelo, et al.
Publicado: (2010)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
por: HE, GUOPING, et al.
Publicado: (2014)

BRAF V600E and lymph node metastases in papillary thyroid cancer
por: Chen, Pan, et al.
Publicado: (2020)

Preoperative BRAF(V600E) mutation detection in thyroid carcinoma by immunocytochemistry
por: Swan, Kristine Zøylner, et al.
Publicado: (2022)

BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013)

Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma
por: Li, Qian, et al.
Publicado: (2017)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)

Selective immunocapture and light-controlled traceless release of transiently caged proteins
por: Rakauskaitė, Rasa, et al.
Publicado: (2021)

BRAF(V600E) mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas
por: Takano, T, et al.
Publicado: (2007)

Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
por: Rowe, Leslie R, et al.
Publicado: (2006)

Restoring Radioiodine Uptake in BRAF V600E–Mutated Papillary Thyroid Cancer
por: Huillard, Olivier, et al.
Publicado: (2017)

Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma
por: Yan, Changjiao, et al.
Publicado: (2019)

A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer
por: Robbins, Richard J., et al.
Publicado: (2020)

Artificial intelligence to predict the BRAF(V600E) mutation in patients with thyroid cancer
por: Yoon, Jiyoung, et al.
Publicado: (2020)

Risk and Prognostic Factors for BRAF(V600E) Mutations in Papillary Thyroid Carcinoma
por: Wei, Xiaojing, et al.
Publicado: (2022)

Induction of the BRAF(V600E) Mutation in Thyroid Cells Leads to Frequent Hypermethylation
por: Yi, Jin Wook, et al.
Publicado: (2022)

BRAF V600E and Novel Somatic Mutations in Thyroid Cancer of Libyan Patients
por: Tounsi-Guettiti, Haifa, et al.
Publicado: (2022)

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
por: Lang, Matthias, et al.
Publicado: (2023)

Sacral metastases in a patient with BRAF V600E+ papillary thyroid carcinoma
por: Bhethanabotla, Rohith M, et al.
Publicado: (2023)

The BRAF(V600E) mutation analysis and risk stratification in papillary thyroid carcinoma
por: Scheffel, Rafael Selbach, et al.
Publicado: (2020)

Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes
por: Gedvilaite, Alma, et al.
Publicado: (2015)

The role of BRAF V600 mutation in melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qhpf5oii08eosj7nd0ikh8rqq4